Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-10

Clinical Trial Update: Hypercapnia to Prevent Secondary Ischemia in SAH [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating hypercapnia to prevent secondary ischemia after aneurysmal subarachnoid hemorrhage has completed. The record lists the condition as ane…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 1 | Status: COMPLETED